These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16629457)

  • 1. [Non-surgical treatment for pancreatic cancer].
    Okusaka T; Ueno H; Ikeda M; Morizane C
    Nihon Shokakibyo Gakkai Zasshi; 2006 Apr; 103(4):391-7. PubMed ID: 16629457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Present status of chemotherapy for colorectal cancer in countries outside of Japan].
    Doi T; Ohtsu A
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():368-73. PubMed ID: 14574915
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent updates on the role of chemotherapy in pancreatic cancer.
    Burris HA
    Semin Oncol; 2005 Aug; 32(4 Suppl 6):S1-3. PubMed ID: 16143160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future strategies for treating metastatic pancreatic cancer.
    Berlin JD
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):510-2. PubMed ID: 16163230
    [No Abstract]   [Full Text] [Related]  

  • 5. Palliative chemotherapy for pancreatic malignancies.
    Mehta SP
    Surg Clin North Am; 2010 Apr; 90(2):365-75. PubMed ID: 20362792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in chemotherapy for advanced gastric cancer].
    Xu RH; Teng KY
    Ai Zheng; 2009 Oct; 28(10):1108-13. PubMed ID: 19799823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status and future directions of chemotherapy for pancreatic cancer].
    Furuse J
    Nihon Shokakibyo Gakkai Zasshi; 2013 Dec; 110(12):2060-5. PubMed ID: 24305093
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent important insights into treatment of pancreatic cancer].
    Abe N; Sugiyama M; Atomi Y
    Gan To Kagaku Ryoho; 2005 May; 32(5):617-23. PubMed ID: 15918560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The choice of treatment in advanced gastric cancer].
    Pozzo C; Mansueto G
    Tumori; 2007; 93(6):suppl 11-21. PubMed ID: 18338512
    [No Abstract]   [Full Text] [Related]  

  • 10. Gemcitabine-based combination treatment of pancreatic cancer.
    Heinemann V
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):25-35. PubMed ID: 11894005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy for pancreatic cancer.
    Ko AH; Tempero MA
    Semin Radiat Oncol; 2005 Oct; 15(4):245-53. PubMed ID: 16183478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gemcitabine-based combinations in inoperable pancreatic cancers].
    Louvet C; André T; Artru P
    Bull Cancer; 2002 Aug; 89 Spec No():S96-101. PubMed ID: 12449038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In focus: advanced pancreatic cancer.
    Kindler HL
    Clin Adv Hematol Oncol; 2005 May; 3(5):420-2. PubMed ID: 16167016
    [No Abstract]   [Full Text] [Related]  

  • 14. Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials.
    Heinemann V
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):9-16. PubMed ID: 12577228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer.
    Yamauchi J; Kanai M; Matsumoto S; Nishimura T; Yazumi S; Kami K; Kawaguchi Y; Yasuda H; Kitano T; Misawa A; Ishiguro H; Yoshikawa K; Yanagihara K; Fukushima M; Doi R; Chiba T
    Pancreas; 2008 Apr; 36(3):327-8. PubMed ID: 18362852
    [No Abstract]   [Full Text] [Related]  

  • 17. [Maintenance strategies for advanced pancreatic cancer: Rationale and issues].
    Turpin A; Chevalier H; Neuzillet C
    Bull Cancer; 2018 Sep; 105(9):739-741. PubMed ID: 30029762
    [No Abstract]   [Full Text] [Related]  

  • 18. Modified FOLFIRINOX for Locally Advanced and Metastatic Pancreatic Cancer Patients Resistant to Gemcitabine and S-1 in Japan: A Single Institutional Experience.
    Umemura A; Nitta H; Sasaki A; Takahara T; Hasegawa Y; Wakabayashi G
    Hepatogastroenterology; 2014 May; 61(131):814-20. PubMed ID: 26176079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives].
    Murakami Y; Uemura K; Sudo T
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1661-9. PubMed ID: 21971141
    [No Abstract]   [Full Text] [Related]  

  • 20. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
    Vaccaro V; Sperduti I; Milella M
    N Engl J Med; 2011 Aug; 365(8):768-9; author reply 769. PubMed ID: 21864184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.